Camurus AB (CHIX:CAMXS) ROE % Adjusted to Book Value : 1.28% (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Camurus AB ROE % Adjusted to Book Value?

Camurus AB's ROE % for the quarter that ended in Sep. 2024 was 17.13%. Camurus AB's PB Ratio for the quarter that ended in Sep. 2024 was 13.37. Camurus AB's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 1.28%.

Camurus AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Camurus AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB ROE % Adjusted to Book Value Chart

Camurus AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-9.52

-1.90

-1.14

0.42

3.21

Camurus AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															2.23	-0.38	1.39	0.97	1.28

Competitive Comparison of Camurus AB's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Camurus AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Camurus AB's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Camurus AB's ROE % Adjusted to Book Value falls into.

Camurus AB ROE % Adjusted to Book Value Calculation

Camurus AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	34.69%	/	10.80
	=	3.21%

Camurus AB's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	17.13%	/	13.37
	=	1.28%

Camurus AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Camurus AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Camurus AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (CHIX:CAMXs) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

CAMRF:USA CAMX:Sweden 0RD1:UK 7CA:Germany

Address

Ideon Science Park, Lund, SWE, SE-223 70

Website

https://www.camurus.com

Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

No Headlines